|
1
|
Nishi T and Forgac M: The vacuolar
(H+)-ATPases-nature's most versatile proton pumps. Nat
Rev Mol Cell Biol. 3:94–103. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Marshansky V, Rubinstein JL and Grüber G:
Eukaryotic V-ATPase: Novel structural findings and functional
insights. Biochimica Biophy Acta. 1837:857–879. 2014. View Article : Google Scholar
|
|
3
|
Breton S and Brown D: Regulation of
luminal acidification by the V-ATPase. Physiology (Bethesda).
28:318–329. 2013.PubMed/NCBI
|
|
4
|
Sun-Wada GH and Wada Y: Vacuolar-type
proton pump ATPases: Acidification and pathological relationships.
Histol Histopathol. 28:805–815. 2013.PubMed/NCBI
|
|
5
|
Barar J and Omidi Y: Dysregulated pH in
tumor microenvironment checkmates cancer therapy. BioImpacts.
3:149–162. 2013.PubMed/NCBI
|
|
6
|
Chung C, Mader CC, Schmitz JC, Atladottir
J, Fitchev P, Cornwell ML, Koleske AJ, Crawford SE and Gorelick F:
The vacuolar-ATPase modulates matrix metalloproteinase isoforms in
human pancreatic cancer. Lab Invest. 91:732–743. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sennoune SR and Martinez-Zaguilan R:
Vacuolar H(+)-ATPase signaling pathway in cancer. Curr Protein Pept
Sci. 13:152–163. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fogarty FM, O'Keeffe J, Zhadanov A,
Papkovsky D, Ayllon V and O'Connor R: HRG-1 enhances cancer cell
invasive potential and couples glucose metabolism to
cytosolic/extracellular pH gradient regulation by the vacuolar-H(+)
ATPase. Oncogene. 33:4653–4663. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nakashima S, Hiraku Y, Tada-Oikawa S,
Hishita T, Gabazza EC, Tamaki S, Imoto I, Adachi Y and Kawanishi S:
Vacuolar H+-ATPase inhibitor induces apoptosis via
lysosomal dysfunction in the human gastric cancer cell line MKN-1.
J Biochem. 134:359–364. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yan Y, Denef N and Schüpbach T: The
vacuolar proton pump, V-ATPase, is required for notch signaling and
endosomal trafficking in drosophila. Dev Cell. 17:387–402. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Marshansky V and Futai M: The V-type
H+-ATPase in vesicular trafficking: Targeting,
regulation and function. Curr Opin Cell Biol. 20:415–426. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lee GH, Kim DS, Kim HT, Lee JW, Chung CH,
Ahn T, Lim JM, Kim IK, Chae HJ and Kim HR: Enhanced lysosomal
activity is involved in Bax inhibitor-1-induced regulation of the
endoplasmic reticulum (ER) stress response and cell death against
ER stress: Involvement of vacuolar H+-ATPase (V-ATPase).
J Biol Chem. 286:24743–24753. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Avnet S, Di Pompo G, Lemma S, Salerno M,
Perut F, Bonuccelli G, Granchi D, Zini N and Baldini N: V-ATPase is
a candidate therapeutic target for Ewing sarcoma. Biochim Biophys
Acta. 1832:1105–1116. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hernandez A, Serrano-Bueno G,
Perez-Castineira JR and Serrano A: Intracellular proton pumps as
targets in chemotherapy: V-ATPases and cancer. Curr Pharm Des.
18:1383–1394. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Graham RM, Thompson JW and Webster KA:
Inhibition of the vacuolar ATPase induces Bnip3-dependent death of
cancer cells and a reduction in tumor burden and metastasis.
Oncotarget. 5:1162–1173. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Luciani F, Spada M, De Milito A, Molinari
A, Rivoltini L, Montinaro A, Marra M, Lugini L, Logozzi M, Lozupone
F, et al: Effect of proton pump inhibitor pretreatment on
resistance of solid tumors to cytotoxic drugs. J Nat Cancer Inst.
96:1702–1713. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Morimura T, Fujita K, Akita M, Nagashima M
and Satomi A: The proton pump inhibitor inhibits cell growth and
induces apoptosis in human hepatoblastoma. Pediat Surg Int.
24:1087–1094. 2008. View Article : Google Scholar
|
|
18
|
Baer C, Claus R and Plass C: Genome-wide
epigenetic regulation of miRNAs in cancer. Cancer Res. 73:473–477.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang Y and Taniguchi T: MicroRNAs and DNA
damage response: Implications for cancer therapy. Cell Cycle.
12:32–42. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
von Schwarzenberg K, Wiedmann RM, Oak P,
Schulz S, Zischka H, Wanner G, Efferth T, Trauner D and Vollmar AM:
Mode of cell death induction by pharmacological vacuolar
H+-ATPase (V-ATPase) inhibition. J Biol Chem.
288:1385–1396. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ohta T, Arakawa H, Futagami F, Fushida S,
Kitagawa H, Kayahara M, Nagakawa T, Miwa K, Kurashima K, Numata M,
et al: Bafilomycin A1 induces apoptosis in the human pancreatic
cancer cell line Capan-1. J Pathol. 185:324–330. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hendrix A, Sormunen R, Westbroek W,
Lambein K, Denys H, Sys G, Braems G, Van den Broecke R, Cocquyt V,
Gespach C, et al: Vacuolar H+ ATPase expression and
activity is required for Rab27B-dependent invasive growth and
metastasis of breast cancer. Int J Cancer. 133:843–854. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lu Q, Lu S, Huang L, Wang T, Wan Y, Zhou
CX, Zhang C, Zhang Z and Li X: The expression of V-ATPase is
associated with drug resistance and pathology of non-small-cell
lung cancer. Diagn Pathol. 8:1452013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dechant R, Binda M, Lee SS, Pelet S,
Winderickx J and Peter M: Cytosolic pH is a second messenger for
glucose and regulates the PKA pathway through V-ATPase. EMBO J.
29:2515–2526. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Valapala M, Wilson C, Hose S, Bhutto IA,
Grebe R, Dong A, Greenbaum S, Gu L, Sengupta S, Cano M, et al:
Lysosomal-mediated waste clearance in retinal pigment epithelial
cells is regulated by CRYBA1/βA3/A1-crystallin via V-ATPase-MTORC1
signaling. Autophagy. 10:480–496. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang CS, Jiang B, Li M, Zhu M, Peng Y,
Zhang YL, Wu YQ, Li TY, Liang Y, Lu Z, et al: The lysosomal
v-ATPase-ragulator complex is a common activator for AMPK and
mTORC1, acting as a switch between catabolism and anabolism. Cell
Metab. 20:526–540. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cao X, Yang Q, Qin J, Zhao S, Li X, Fan J,
Chen W, Zhou Y, Mao H and Yu X: V-ATPase promotes transforming
growth factor-β-induced epithelial-mesenchymal transition of rat
proximal tubular epithelial cells. Am J Physiol Renal Physiol.
302:F1121–F1132. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jung JY and Robinson CM: Interleukin-27
inhibits phagosomal acidification by blocking vacuolar ATPases.
Cytokine. 62:202–205. 2013. View Article : Google Scholar : PubMed/NCBI
|
